Journal of Obstetrics, Gynecology and Cancer Research

Published by: Kowsar

New Guidelines for Screening of Cervical Cancer Around the World

Mojgan Karimi Zarchi 1 , * and Soraya Teimoori 2
Authors Information
1 Gynecology Department, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Young Researchers and Elites Club, Faculty of Medicine, Islamic Azad University, Yazd, Iran
Article information
  • Journal of Obstetrics, Gynecology and Cancer Research: November 2017, 2 (4); e65824
  • Published Online: November 30, 2017
  • Article Type: Letter
  • Received: September 4, 2017
  • Accepted: October 11, 2017
  • DOI: 10.5812/jogcr.65824

To Cite: Karimi Zarchi M, Teimoori S. New Guidelines for Screening of Cervical Cancer Around the World, J Obstet Gynecol Cancer Res. 2017 ;2(4):e65824. doi: 10.5812/jogcr.65824.

Copyright: Copyright © 2017, Journal of Obstetrics, Gynecology and Cancer Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Acknowledgements
Footnotes
References
  • 1. Smith RA, Andrews K, Brooks D, DeSantis CE, Fedewa SA, Lortet-Tieulent J, et al. Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2016;66(2):96-114. doi: 10.3322/caac.21336. [PubMed: 26797525].
  • 2. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. [PubMed: 23199969].
  • 3. Teoh DG, Marriott AE, Isaksson Vogel R, Marriott RT, Lais CW, Downs LJ, et al. Adherence to the 2012 national cervical cancer screening guidelines: a pilot study. Am J Obstet Gynecol. 2015;212(1):62 e1-9. doi: 10.1016/j.ajog.2014.06.057. [PubMed: 24992692].
  • 4. Lees BF, Erickson BK, Huh WK. Cervical cancer screening: evidence behind the guidelines. Am J Obstet Gynecol. 2016;214(4):438-43. doi: 10.1016/j.ajog.2015.10.147. [PubMed: 26519782].
  • 5. Aboul-Fotouh MEM, Hana IT. Clinical validation of high risk HPV DNA testing versus ThinPrep cytology for primary cervical cancer screening. Middle East Fertil Soc J. 2013;18(2):102-9. doi: 10.1016/j.mefs.2012.12.001.
  • 6. Karimi-Zarchi M, Zanbagh L, Shafii A, Taghipour-Zahir S, Teimoori S, Yazdian-Anari P. Comparison of Pap Smear and Colposcopy in Screening for Cervical Cancer in Patients with Secondary Immunodeficiency. Electron Physician. 2015;7(7):1542-8. doi: 10.19082/1542. [PubMed: 26767111].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader